Pulse Biosciences to Present at Piper Sandler 38th Annual Healthcare Conference
Business Wire•19/11/2026•16:05 ET
1
Key Highlights
- ➤Pulse Biosciences (PLSE) to present at Piper Sandler healthcare conference December 3
- ➤Management presentation scheduled for 8:50 a.m. ET in New York
- ➤Live and recorded webcast will be available on company investor website
- ➤Company developing nPulse technology for atrial fibrillation treatment
Pulse Biosciences to Present at Piper Sandler 38(th) Annual Healthcare Conference
Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced plans to participate in the upcoming Piper Sandler 38(th) Annual Healthcare Conference in New York, NY.
Get started
Create a free account to read the full story.
